A year ago, I started writing. I wrote to process what I had seen and done and to prepare for what I knew was to come. It was inevitable. Humans would return to their normal activities, and despite mine and so many others’ advice, would do so without utilizing mitigating behaviors or respect for others. … Read More »
Dive Brief: A new study of one the nation’s busiest public hospitals in the Western Journal of Medicine concluded that COVID-19 led to a massive drop-off in emergency department visits during the first few weeks of the pandemic. A second survey by researchers at The Commonwealth Fund found that COVID-19 also interfered with Medicare enrollees’ access… Read More »
Infertility affects one in seven men of reproductive age worldwide. One idea for treating male sterility is spermatogonial stem cell (SSC) therapy. In this approach, sperm stem cells in the testis are transferred to a test tube, cultured and nudged into becoming fully fledged sperm. However, a key bottleneck has been identifying just the right… Read More »
Lung cancer is the second most prevalent cancer in the US, and the deadliest cancer killer. In 2020, an estimated 135,720 people will die from the disease — more than breast, colon, and prostate cancers combined. I’ll never forget meeting new, advanced-stage lung cancer patients who ask if their diagnosis could have somehow been made… Read More »
On the heels of early positive COVID-19 vaccine data, the CEOs at BioNTech and Pfizer are gearing up for a late-stage trial and talking up potential approvals later this year. In separate interviews this week, Pfizer CEO Albert Bourla and BioNTech CEO Ugur Sahin said their mRNA vaccine candidate could be ready to submit to regulators in the fall or winter, respectively, pending success in… Read More »